MARKER THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-6.5M | $-6.5M | — | $1.6M |
| FY2017 | $-8.4M | $-8.4M | $0 | $2.7M |
| FY2018 | $-14.5M | $-14.6M | $147.7K | $16.4M |
| FY2019 | $-18.3M | $-18.7M | $375.0K | $5.4M |
| FY2020 | $-20.0M | $-20.0M | — | $5.2M |
| FY2021 | $-27.3M | $-27.3M | — | $6.0M |
| FY2022 | $-27.0M | $-27.0M | — | $3.3M |
| FY2023 | $-16.4M | $-16.4M | — | $858.3K |
| FY2024 | $-10.9M | $-10.9M | — | $245.9K |
| FY2025 | $-12.0M | $-12.0M | — | $537.5K |